Mesuximide
(Redirected from Celontin)
Mesuximide[edit | edit source]
Mesuximide is a succinimide anticonvulsant medication primarily used in the treatment of epilepsy. It is particularly effective in managing absence seizures, which are characterized by brief, sudden lapses in attention. Mesuximide is part of a class of medications known as antiepileptic drugs (AEDs), which work by stabilizing electrical activity in the brain.
Pharmacology[edit | edit source]
Mesuximide functions by modulating the activity of calcium channels in the brain. It is believed to reduce the influx of calcium ions through T-type calcium channels, which are implicated in the generation of absence seizures. By inhibiting these channels, mesuximide helps to prevent the abnormal electrical activity that leads to seizures.
Clinical Use[edit | edit source]
Mesuximide is specifically indicated for the treatment of absence seizures, also known as petit mal seizures. These seizures are most commonly seen in children and are characterized by a brief loss of consciousness or "staring spells." Mesuximide is often used when other medications, such as ethosuximide, are not effective or cause intolerable side effects.
Side Effects[edit | edit source]
Common side effects of mesuximide include drowsiness, dizziness, and gastrointestinal disturbances such as nausea and vomiting. More serious side effects can include blood dyscrasias, such as leukopenia and thrombocytopenia, as well as liver toxicity. Patients taking mesuximide require regular monitoring of blood counts and liver function tests.
Dosage and Administration[edit | edit source]
Mesuximide is typically administered orally in capsule form. The dosage is individualized based on the patient's age, weight, and response to the medication. It is important to follow the prescribing physician's instructions carefully and not to discontinue the medication abruptly, as this can lead to an increase in seizure frequency.
Mechanism of Action[edit | edit source]
The exact mechanism by which mesuximide exerts its anticonvulsant effects is not fully understood. However, it is known to affect the thalamocortical relay neurons, which play a crucial role in the generation of absence seizures. By modulating the activity of these neurons, mesuximide helps to stabilize the electrical activity in the brain.
History[edit | edit source]
Mesuximide was developed as part of a class of succinimide anticonvulsants in the mid-20th century. It was introduced as an alternative to other antiepileptic drugs that had more severe side effects or were less effective in treating absence seizures.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Deepika vegiraju, Prab R. Tumpati, MD